Position in TERN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,044,379
New position
Shares Held
171,555
first reported quarter
Ownership
0.149%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR Arbitrage LLC holds $185,136,566 across 7 Biotechnology names. TERN ranks #4 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
5,843,849 | $84,502,056 | |
| 2 | DAWN |
Day One Biopharmaceuticals, Inc.
|
2,462,154 | $52,788,581 | |
| 3 | ACLX |
Arcellx, Inc.
|
231,730 | $26,607,238 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
This page
|
171,555 | $9,044,379 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
146,604 | $5,897,878 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
98,028 | $3,893,672 | |
| 7 | RNA |
Atrium Therapeutics, Inc.
|
179,713 | $2,402,762 |
All Filings in TERN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,044,379 | 171,555 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||